These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7945569)

  • 1. Binding characteristics of the calcium channel antagonist [3H]-nitrendipine in tissues from ethanol-dependent rats.
    Guppy LJ; Littleton JM
    Alcohol Alcohol; 1994 May; 29(3):283-93. PubMed ID: 7945569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course and genetic variation in the regulation of calcium channel antagonist binding sites in rodent tissues during the induction of ethanol physical dependence and withdrawal.
    Guppy LJ; Crabbe JC; Littleton JM
    Alcohol Alcohol; 1995 Sep; 30(5):607-15. PubMed ID: 8554643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The time course of up-regulation and down-regulation of dihydropyridine binding sites during the development of physical dependence on ethanol.
    Guppy LJ; Littleton JM
    Proc West Pharmacol Soc; 1994; 37():77-80. PubMed ID: 7984679
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
    Schoemaker H; Langer SZ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ; Murphy KM; Snyder SH
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are changes in neuronal calcium channels involved in ethanol tolerance?
    Dolin SJ; Little HJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):985-91. PubMed ID: 2570870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical dihydropyridine binding sites are unaltered in human alcoholic brain.
    Kril JJ; Gundlach AL; Dodd PR; Johnston GA; Harper CG
    Ann Neurol; 1989 Sep; 26(3):395-7. PubMed ID: 2529812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged ethinyl estradiol treatment on calcium channel binding and in vivo calcium-mediated hemodynamic responses in ovariectomized rats.
    Bowling N; Bloomquist WE; Cohen ML; Bryant HU; Cole HW; Magee DE; Rowley ER; Vlahos CJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):218-25. PubMed ID: 9103500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioligand binding studies on some dihydropyridine analogues as probes of the dihydropyridine receptor.
    Kettmann V; Drímal J; Svétlík J
    Pharmazie; 1996 Oct; 51(10):747-50. PubMed ID: 8941943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prolonged exposure to ethanol in vivo on functional parameters and sensitivity to nitrendipine in the isolated rat heart.
    Guppy LJ; Littleton JM
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):414-9. PubMed ID: 10471001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of dihydropyridine calcium antagonist binding sites in the rat hippocampus following neurochemical lesions.
    Bolger GT; Basile AS; Janowsky AJ; Paul SM; Skolnick P
    J Neurosci Res; 1987; 17(3):285-90. PubMed ID: 3037095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon centered radicals reduce the density of L-type calcium channels in rat cardiac membranes.
    Matucci R; Bianchi B; Ottaviani MF; Campana S; Bennardini F; Franconi F
    Biochem Biophys Res Commun; 1996 Jun; 223(1):85-90. PubMed ID: 8660384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased 1,4-dihydropyridine binding sites in serum-stimulated cardiomyocyte hypertrophy.
    Lubic SP; Giacomini KM; Giacomini JC
    J Pharmacol Exp Ther; 1994 Aug; 270(2):697-701. PubMed ID: 8071861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-delimited G protein-mediated coupling between V1a vasopressin receptor and dihydropyridine binding sites in rat glomerulosa cells.
    Grazzini E; Durroux T; Payet MD; Bilodeau L; Gallo-Payet N; Guillon G
    Mol Pharmacol; 1996 Nov; 50(5):1273-83. PubMed ID: 8913359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased [3H] PN 200-110 binding sites in the myocardial sarcolemmal membrane in endotoxin shock rats].
    Motoyama Y
    Masui; 1994 Jan; 43(1):7-12. PubMed ID: 8309058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel.
    Skeen GA; White HS; Twyman RE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):30-8. PubMed ID: 7965728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.